[144] Axon Enterprise, Inc. SEC Filing

Rhea-AI Filing Summary

Axon Enterprise, Inc. filed a Form 144 notifying of a proposed sale of 15,919 shares of common stock through Merrill Lynch on 08/15/2025 on Nasdaq with an aggregate market value of $11,879,088.00. The shares were acquired as an equity award from the issuer on 08/13/2025 and payment is indicated as cash. The filer also reported four prior sales during the past three months totaling 15,810 shares on 05/21/2025, 06/17/2025, 08/07/2025 and 08/12/2025 with combined gross proceeds of $12,110,841.00. The filing includes the required attestation that the seller is not aware of undisclosed material adverse information.

Positive

• Transparent disclosure of proposed sale details including broker, sale date, acquisition date, and payment method
• Filing includes attestation that the seller is not aware of undisclosed material adverse information

Negative

• Significant insider selling with 15,919 shares proposed for sale and prior three-month sales totaling 15,810 shares
• Large aggregate values reported ($11,879,088 proposed; $12,110,841 prior proceeds) which may be material to some investors

Insights

Securities/Equity Analyst

TL;DR: Insider notified a planned sale of 15,919 shares acquired via an equity award; record of prior recent sales totaling 15,810 shares.

The Form 144 is a routine disclosure of proposed insider selling. The planned block of 15,919 shares with an aggregate market value of $11.9 million is sizeable in absolute terms but must be viewed alongside prior near-term disposals totaling 15,810 shares and $12.11 million in gross proceeds. This pattern shows active liquidity events by the reporting person rather than a single isolated sale. The filing properly identifies the broker, sale date, acquisition date, and payment method, which supports transparency for market participants.

Corporate Governance Expert

TL;DR: Filing documents compliant insider sale disclosures; multiple recent sales merit attention but are disclosed per Rule 144.

The submission contains the required elements for Rule 144 notice: issuer, broker, number of shares, acquisition method (equity award), and dates. The seller certified lack of undisclosed material adverse information. From a governance perspective, repeated sales by an insider are noteworthy for monitoring but the form itself indicates compliance with disclosure obligations. No information in the filing indicates misconduct or undisclosed company-specific material events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch, Pierce, Fenner & Smith Inc. 14636 N Scottsdale Rd. Suite 325 Scottsdale AZ 85254	15919	11879088.00	78504440	08/15/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/13/2025	Equity Award	Issuer			15919	08/13/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joshua Isner 17800 N. 85th St. Scottsdale AZ 85255	Common Stock	08/12/2025	2500	1921425.00
Joshua Isner 17800 N. 85th St., Scottsdale AZ 85255	Common Stock	08/07/2025	2500	2177047.00
Joshua Isner 17800 N. 85th St., Scottsdale AZ 85255	Common Stock	06/17/2025	905	702558.00
Joshua Isner 17800 N. 85th St., Scottsdale AZ 85255	Common Stock	05/21/2025	9905	7309811.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Axon (AXON) Form 144 filed on this notice report?

The Form 144 reports a proposed sale of 15,919 shares of common stock via Merrill Lynch on 08/15/2025 with an aggregate market value of $11,879,088.00.

How were the 15,919 shares acquired according to the filing?

The shares were acquired as an equity award from the issuer on 08/13/2025 and the filing lists payment as cash.

Has the filer sold Axon shares recently?

Yes. The filer sold 2,500 shares on 08/12/2025, 2,500 shares on 08/07/2025, 905 shares on 06/17/2025, and 9,905 shares on 05/21/2025, totaling 15,810 shares with combined gross proceeds of $12,110,841.00.

Which broker will handle the proposed sale?

Merrill Lynch, Pierce, Fenner & Smith Inc., 14636 N Scottsdale Rd. Suite 325 Scottsdale AZ 85254.

On which exchange is the sale intended to occur?

The proposed sale is indicated to occur on Nasdaq.

Does the filing state any undisclosed material information about Axon?

The filer attests they do not know any material adverse information about the issuer that has not been publicly disclosed.